Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans

Chadwick, C.; Marven, S. M.; Vora, A. J.
February 2004
Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p451
Academic Journal
Summary:Bronchiolitis obliterans (BO) is a manifestation of chronic graft-versus-host disease (GVHD) after allogeneic haemopoietic stem cell transplantation. Complications associated with this include persistent air-leak syndromes such as pneumothorax. Many methods have been described for treating this condition, both surgical and nonsurgical. We describe an 8-year-old boy with acute lymphoblastic leukaemia complicated by chronic GVHD-related BO, and subsequent pneumothorax with persistent air leak, who was treated successfully with autologous blood pleurodesis.Bone Marrow Transplantation (2004) 33, 451-453. doi:10.1038/sj.bmt.1704370 Published online 29 December 2003


Related Articles

  • Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease. Reubsaet, L L; de Pagter, A P J; van Baarle, D; Keukens, L; Nanlohy, N; Sanders, E A M; Prakken, B J; Boelens, J J; de Kleer, I M // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p502 

    In adult patients, regulatory CD4+FOXP3+ T cells are suggested to have a role in the control of allo-reactive disease after hematopoietic SCT (HSCT). We compared CD4+FOXP3+ T-cell reconstitution after unrelated cord blood (UCB), matched unrelated donor (MUD) and matched sibling donor (MSD) HSCT...

  • Invasive microsporidiosis in allogeneic haematopoietic SCT recipients. Ambrosioni, J.; van Delden, C.; Krause, K. H.; Bouchuiguir-Wafa, C.; Nagy, M.; Passweg, J.; Chalandon, Y. // Bone Marrow Transplantation;Jul2010, Vol. 45 Issue 7, p1249 

    The article presents a case study of a 49-year-old woman admitted for allo-hematopoietic stem cell transplantation (HSCT) from an unrelated donor human leukocyte allele (HLA) matched 9/10 to treat her Hodgkin's lymphoma (HL) 20 months prior to the admission. Treatments given to the patient...

  • Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation. Hägglund, H; Remberger, M; Ringden, O // Bone Marrow Transplantation;Dec2014, Vol. 49 Issue 12, p1541 

    The article discusses the follow-up of a randomized trial in 1998 which compares intraosseous (i.o.) and i.v. transplantation of allogeneic haematopoietic stem cells. The probability of chronic graft versus host disease (GVHD) was deemed similar to both transplantation. Induction of persistent...

  • Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD. Chen, Y-B; McDonough, S; Chen, H; Kennedy, J; Illiano, C; Attar, E C; Ballen, K K; Dey, B R; McAfee, S L; Jagasia, M; Soiffer, R; Spitzer, T R; Ritz, J // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p598 

    Acute intestinal GVHD remains a major source of morbidity after allogeneic hematopoietic cell transplantation (HCT). α4β7 integrin is a cell surface molecule that mediates lymphocyte trafficking to intestinal tissue. In this analysis, peripheral blood was collected at the time of...

  • Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD. Glotzbecker, B; Ho, V T; Aldridge, J; Kim, H T; Horowitz, G; Ritz, J; Soiffer, R; Avigan, D; Rosenblatt, J // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p593 

    Vitamin D, a hormone involved in bone and calcium homeostasis, has been shown to have potent immunomodulatory effects. We performed a retrospective cohort analysis to evaluate whether monohydroxyvitamin D levels before allogeneic hematopoietic SCT (HSCT) correlate with the risk of GVHD....

  • Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic hematopoietic SCT. Palfreyman, E; Song, K; Nantel, S // Bone Marrow Transplantation;Aug2013, Vol. 48 Issue 8, p1138 

    The article presents a case study of a 39-year-old female who underwent a fully ablative allogeneic hematopoietic stem cell transplantation (alloSCT) in August 1997 with her human leukocyte antigen (HLA)-matched male sibling as the donor. It discusses various complications after the transplant...

  • Neutrophils: Bugging transplantation. Kugelberg, Elisabeth // Nature Reviews Immunology;Jul2014, Vol. 14 Issue 7, p430 

    The article explores the immune response of graft-versus-host disease, a common complication of allogeneic haematopoietic stem cell transplantation. It provides an overview of a study which reveals that germ-free mice did not depict an increased frequency of neutrophils following total body...

  • Chronic graft-versus-host disease in the era of reduced-intensity conditioning. Subramaniam, D. S.; Fowler, D. H.; Pavletic, S. Z. // Leukemia (08876924);May2007, Vol. 21 Issue 5, p853 

    In the past decade the field of hematopoietic stem cell transplantation has entered a new era with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on the incidence of chronic graft-versus-host disease (GVHD) has not been evaluated systematically. Factors...

  • Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. Beri, R.; Chunduri, S.; Sweiss, K.; Peace, D. J.; Mactal-Haaf, C.; Dobogai, L. C.; Shord, S.; Quigley, J. G.; Chen, Y. H.; Mahmud, N.; Rondelli, D. // Bone Marrow Transplantation;Feb2010, Vol. 45 Issue 2, p249 

    A pretransplant test dose of i.v. BU was previously used in pediatric patients undergoing a reduced-intensity allogeneic hematopoietic SCT (HSCT). Here, we used a BU test dose in 23 adult patients who were not pancytopenic and underwent a myeloablative allogeneic HSCT prepared with fludarabine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics